Gold-standard RT-PCR detection of SARS-CoV-2 at rapid speed: a solution for asymptomatic screening.
Evidence to date strongly points to rapid RT-PCR tests as the optimal solution for asymptomatic screening, based on performance characteristics equivalent to gold-standard lab-based testing for SARS-CoV-2 and operational characteristics enabling rapid, decentralized deployment.
Comparison of rapid RT-LAMP and rapid RT-PCR methods for the detection of SARS-CoV-2 RNA
POC NAATs are a promising approach to achieve a massive expansion in testing, and a diverse range of POC tests based on RT-PCR and isothermal amplification such as RT-LAMP offer rapid, decentralized options. A rapid RT-PCR test such as the Accula SARS-CoV-2 Test is an ideal solution that addresses the requirements for timely results with best-in-class performance.
Robust detection of SARS-CoV-2 variants at the point-of-care
This white paper describes how relevant mutations are identified and assessed for diagnostic impact in real-time through an ongoing pandemic, with a focus on the successful coverage of SARS-CoV-2 variants by the point-of-care Thermo Fisher Scientific™ Accula™ SARS-CoV-2 Test.